France Gives Fresh Impetus To Economic Evaluations In Five Year Strategic Plan

France’s health technology appraisal body, HAS, is putting more emphasis on the importance of economic evaluations in light of the rising costs of health technologies, including medicines and medical devices, and increasing budgetary pressures.

French HTA HAS it will work on managing uncertainty associated with innovative new products as part of its new five-year strategy. (Shutterstock)

More from France

More from Market Access